Dernières publications scientifiques

Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patients.

Dietz J, Graf C, Berg CP, Port K, Deterding K, Buggisch P, Peiffer KH, Vermehren J, Dultz G, Geier A, Reiter FP, Bruns T, Schattenberg JM, Durmashkina E, Gustot T, Moreno C, Trauth J, Discher T, Fischer J, Berg T, Kremer AE, Müllhaupt B, Zeuzem S, Sarrazin C

Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patients.

Quantitative Characterization of Rhythmic and Periodic EEG Patterns in Patients in a Coma After Cardiac Arrest and Association With Outcome.

van Putten MJAM, Ruijter BJ, Horn J, van Rootselaar AF, Tromp SC, van Kranen-Mastenbroek V, Gaspard N, Hofmeijer J

Quantitative Characterization of Rhythmic and Periodic EEG Patterns in Patients in a Coma After Cardiac Arrest and Association With Outcome.

Validation of a targeted next-generation sequencing panel for pancreatic ductal adenocarcinomas.

Racu ML, Schiavo AA, Van Campenhout C, De Nève N, Masuy T, Maris C, Decaestecker C, Remmelink M, Salmon I, D'Haene N

Validation of a targeted next-generation sequencing panel for pancreatic ductal adenocarcinomas.

Validation of a targeted next-generation sequencing panel for pancreatic ductal adenocarcinomas.

Racu ML, Schiavo AA, Van Campenhout C, De Nève N, Masuy T, Maris C, Decaestecker C, Remmelink M, Salmon I, D'Haene N

Validation of a targeted next-generation sequencing panel for pancreatic ductal adenocarcinomas.

Validation of a targeted next-generation sequencing panel for pancreatic ductal adenocarcinomas.

Racu ML, Schiavo AA, Van Campenhout C, De Nève N, Masuy T, Maris C, Decaestecker C, Remmelink M, Salmon I, D'Haene N

Validation of a targeted next-generation sequencing panel for pancreatic ductal adenocarcinomas.

Validation of a targeted next-generation sequencing panel for pancreatic ductal adenocarcinomas.

Racu ML, Schiavo AA, Van Campenhout C, De Nève N, Masuy T, Maris C, Decaestecker C, Remmelink M, Salmon I, D'Haene N

Validation of a targeted next-generation sequencing panel for pancreatic ductal adenocarcinomas.

Validation of a targeted next-generation sequencing panel for pancreatic ductal adenocarcinomas.

Racu ML, Schiavo AA, Van Campenhout C, De Nève N, Masuy T, Maris C, Decaestecker C, Remmelink M, Salmon I, D'Haene N

Validation of a targeted next-generation sequencing panel for pancreatic ductal adenocarcinomas.

Validation of a targeted next-generation sequencing panel for pancreatic ductal adenocarcinomas.

Racu ML, Schiavo AA, Van Campenhout C, De Nève N, Masuy T, Maris C, Decaestecker C, Remmelink M, Salmon I, D'Haene N

Validation of a targeted next-generation sequencing panel for pancreatic ductal adenocarcinomas.

Validation of a targeted next-generation sequencing panel for pancreatic ductal adenocarcinomas.

Racu ML, Schiavo AA, Van Campenhout C, De Nève N, Masuy T, Maris C, Decaestecker C, Remmelink M, Salmon I, D'Haene N

Validation of a targeted next-generation sequencing panel for pancreatic ductal adenocarcinomas.

Bordet hospital

Institut Jules Bordet

Consultez toutes les publications scientifiques de Jules Bordet

Publications scientifiques de Jules Bordet

Erasme hospital

Hôpital Erasme

Consultez toutes les publications scientifiques d'Erasmus

Publications scientifiques d'Erasmus

Huderf hospital

Hôpital pédiatrique Reine Fabiola

Voir toutes les publications scientifiques de l'Hôpital pédiatrique Reine Fabiola

Publications scientifiques de l'Hôpital pour enfants Reine Fabiola